Surviving Lymphoma: Early Detection Is An Important Factor

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's lymphoma is 71% and the 5-year survival rate for patients diagnosed with Hodgkin's Lymphoma is 86%.

This number is an average and varies widely depending on variables including the age of a patient, the stage of the disease (i.e., how far it has advanced), the patient's overall health and socioeconomic status. Generally speaking, however, lymphoma treatment and survival rates are improving.

As with any cancer, early detection of lymphoma is the single most important factor in a successful outcome.

After the Diagnosis

Following diagnosis, there are multiple treatment options and significant consultations and even experimentation might be required to find the best treatment for a given patient.

A positive mental outlook is also important as depression can interfere with a lymphoma patient's ability to respond to and recover from treatment. Depression will decrease an individual's motivation to follow through with therapy, medication, and other patient-dependent aspects of recovery.

LymphomaInfo.net offers many pages that lead the way to a better understanding of lymphoma detection, symptoms and treatment. Whether you have been recently diagnosed with lymphoma or have completed treatment, we connect you with other patients and survivors of Hodgkin and non-Hodgkin lymphomas. Whether you need general information or are looking for specific products such as medical ID bracelets, a community to provide information and support should be seen as an essential component of any recovery effort.

Lymphoma Survivor Support and Issues

Source: Healthline, MedicineNet
Photo: Pexels

More Articles

More Articles

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

Small lymphocytic lymphoma (SLL), is a type of non-Hodgkin lymphoma characterized by an excess of white blood cells in the...

Lymphoplasmacytic Lymphoma (LPL) is an indolent (slow growing) cancer that affects plasma cells. A plasma cell...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...

Treatment for Non-Hodgkin’s Lymphomas (NHL) differs from patient to patient. The regimen used depends on the type of...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

The question of what the difference is between leukemia and lymphoma is a commonly asked question. We should start by saying that emerging...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

As one of two primary categories of lymphatic cancer, Hodgkin's lymphoma (HL) attacks the patient's white...

The diagnosis of a low grade B cell lymphoma is both a specific and a non-specific diagnosis that contains the following components:

What...

Hearing about lymphoma recurrence is about the least-welcome news a patient can hear. But what exactly does it mean?

To begin, lymphoma...

BEAM chemotherapy is an acronym representing a small family of combination chemotherapy regimens that are used chiefly as salvage regimens in the...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have...